Company intelligence / Profile preview

Metabolife

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Metabolife was a leading U.S. multi-level marketing company selling the ephedra-based weight-loss supplement "Metabolife 356." The product achieved massive commercial success but was linked to thousands of serious adverse events, including deaths. Following regulatory scrutiny and an FDA ban on ephedra-containing supplements in the U.S., the company declared bankruptcy in 2005. Its non–ephedra assets were acquired by Ideasphere Inc.[1][2][3] No current clinical programs exist.

Therapeutic areas: Men's HealthEndocrinology
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

Chemins Laboratories

Beyond the preview

Go deeper on Metabolife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metabolife.

Explore the full profile